デュポン、プロバイオティクスの生産能力拡大のマイルストーンを達成

ニューヨーク州ロチェスター、2019 年 3 月 28 日 - デュポンは、同社のニューヨーク州ロチェスターに建設していた新たな最新鋭のプロバイオティクス発酵設備が竣工したことを発表しました。現時点で世界最大となるこの設備は、プロバイオティクスの生産能力拡大に向けた 1 億ドル近い多面的な投資の一環です。本設備の増強により、臨床試験データを持つ高品質なプロバイオティクスの販売において、デュポンのリーダーシップがさらに強固なものになります。

高用量で、安定性、効能を備えたプロバイオティクスを生産可能な本設備は、現在全面的に稼動可能です。高品質なプロバイオティクスを生産する上で、今回の投資はデュポンのプロバイオティクス生産能力の最適化を担っています。本設備により、お客様のニーズに迅速に対応することが可能になります。

デュポン ニュートリション＆ヘルス プレジデントのMatthias Heinzelは次のように述べています。「当社の新しい発酵設備の完成は、イノベーションをお客様にお届けし、プロバイオティクスを通じた当社の壮大な成長計画を達成するうえで、大きなマイルストーンになります。現在、消費者の健康意識の高まりから、プロバイオティクスの需要が大きく伸びている様子を目の当たりにしています。急速に成長するこの市場に向けて、引き続き力を入れて取り組んでいくことを喜ばしく思います。これにより、世界中のお客様に持続可能な成長もご提供できると考えています」

デュポンはプロバイオティクスの世界的なリーダー企業です。臨床試験データのある菌末をデュポン™ ダニスコ®のポートフォリオで幅広く提供し、消化器系の健康、免疫系の健康、女性の健康をはじめとして、人々のさまざまな健康をサポートしています。特に、HOWARU®製品は、2018 年に、さまざまな業界団体から卓越したイノベーションに贈られる賞を受賞しています。同社は、腸内細菌叢に関連したさらに大規模な投資戦略の一環として、ヒトミルクオリゴ糖 (HMO) の開発にもプロバイオティクスのプラットフォームを活用しています。

デュポンは、2018年末に同社のウィスコンシン州マディソン拠点でもプロバイオティクス生産能力の拡大を完了しています。迅速なサンプル提供が可能になり、お客様へのニーズに即した最終商品の提供に貢献しています。

デュポン ニュートリション＆ヘルスの詳細については、http://www.dupontnutritionandhealth.com/ をご覧ください。

デュポン ニュートリション＆ヘルスについて

ダウ・デュポン特殊化学品事業部門のデュポン ニュートリション＆ヘルスは、食品栄養の徹底した専門知識と、最新の研究や科学知識をもとに、食品、飲料、医薬品そしてサプリメント業界へ比類のない価値を提供します。革新的な問題解決力と、深い消費者インサイトを持つ我々の幅広い製品ポートフォリオは、お客様の持つ問題や課題を、価値あるビジネスチャンスとする事が出来ます。（www.food.dupont.com）

ダウ・デュポン 特殊化学品事業部門について

ダウ・デュポン（NYSE：DWDP）の特殊化学品事業部門は、技術を基盤とした素材、原料、ソリューションの提供を通し、産業や日々の暮らしの変革に貢献する、世界のイノベーションリーダーです。我々は広範な専門知識並びにサイエンスを適用し、エレクトロニクス、トランスポーテーション、住宅・ 建築、健康、食品、安全など、主要マーケットにおけるお客様の卓越したアイデアをイノベーションへと繋げる架け橋となります。ダウ・デュポンは、デュポンとなる予定の特殊化学品事業部門を分割し、独立した上場企業として設立する計画です。（www.dow-dupont.com）

Cautionary Statement Regarding Forward Looking Statements

This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” and similar expressions and variations or negatives of these words.

Forward-looking statements by their nature address matters that are, to varying degrees, uncertain, including statements about the intended distribution of all of the shares of common stock of its wholly-owned subsidiary, Corteva, Inc. (the “Corteva Distribution”). Forward-looking statements, including those related to the DowDuPont’s ability to complete, or to make any filing or take any other action required to be taken to complete, the Corteva Distribution, are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements. Forward-looking statements also involve risks and uncertainties, many of which that are beyond DowDuPont’s control. Some of the important factors that could cause DowDuPont’s actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) ability and costs to achieve all the expected benefits from the Corteva Distribution and the April 1, 2019 distribution by DowDuPont of all of the shares of common stock of Dow Inc. on a pro rata basis to the holders of DowDuPont common stock (the “Dow Distribution”); (ii) the incurrence of significant costs in connection with the Corteva Distribution and the Dow Distribution, including increased costs from supply, service and other arrangements that prior to the Dow Distribution were between entities under the common control of DowDuPont; (iii) risks outside the control of DowDuPont which could impact the decision of the DowDuPont Board of Directors to proceed with the Corteva Distribution, including, among others, global economic conditions, instability in credit markets, declining consumer and business confidence, fluctuating commodity prices and interest rates, volatile foreign currency exchange rates, tax considerations, other challenges that could affect the global economy, specific market conditions in one or more of the industries of the businesses proposed to be separated, and changes in the regulatory or legal environment and the requirement to redeem $12.7 billion of DowDuPont notes if the Corteva Distribution is abandoned or delayed beyond May 1, 2020; (iv) potential liability arising from fraudulent conveyance and similar laws in connection with the Corteva Distribution and/ or the Dow Distribution; (v) disruptions or business uncertainty, including from the Corteva Distribution, could adversely impact DowDuPont’s business or financial performance and its ability to retain and hire key personnel; (vi) uncertainty as to the long-term value of DowDuPont common stock; (vii) potential inability to access the capital markets; and (viii) risks to DowDuPont’s business, operations and results of operations from: the availability of and fluctuations in the cost of feedstocks and energy; balance of supply and demand and the impact of balance on prices; failure to develop and market new products and optimally manage product life cycles; ability, cost and impact on business operations, including the supply chain, of responding to changes in market acceptance, rules, regulations and policies and failure to respond to such changes; outcome of significant litigation, environmental matters and other commitments and contingencies; failure to appropriately manage process safety and product stewardship issues; global economic and capital market conditions, including the continued availability of capital and financing, as well as inflation, interest and currency exchange rates; changes in political conditions, including trade disputes and retaliatory actions; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could result in a significant operational event for DowDuPont, adversely impact demand or production; ability to discover, develop and protect new technologies and to protect and enforce DowDuPont’s intellectual property rights; failure to effectively manage acquisitions, divestitures, alliances, joint ventures and other portfolio changes; unpredictability and severity of catastrophic events, including, but not limited to, acts of terrorism or outbreak of war or hostilities, as well as management’s response to any of the aforementioned factors. These risks are and will be more fully discussed in DowDuPont’s current, quarterly and annual reports and other filings made with the U.S. Securities and Exchange Commission as well as the preliminary registration statement on Form 10 of Corteva, Inc., in each case, as may be amended from time to time in future filings with the SEC. While the list of factors presented here is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DowDuPont’s or Corteva, Inc.’s consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DowDuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part I, Item 1A) of DowDuPont’s 2018 Annual Report on Form 10-K and as set forth in the preliminary registration statement on Form 10 of Corteva, Inc.

デュポンオーバルマーク、デュポンTM、及びTM、SM、®表示のある全ての製品は、米国デュポン社及び関連会社の商標あるいは登録商標です。

本参考資料は、米国時間2019年3月28日にデュポン ニュートリション＆ヘルスが配信したリリースの抄訳です。当資料の正式言語は英語であり、その内容及び解釈については英語が優先されます。

＃　＃　＃

この件に関するお問い合わせは、下記までお願いします。
デュポン株式会社　コーポレート コミュニケーション部 高野
電話　(03)5521－8483